期刊文献+

苯甲酸阿格列汀致大疱性类天疱疮1例

Bullous pemphigoid caused by alogliptin benzoate:a case report
原文传递
导出
摘要 1临床资料患者,男,63岁,因四肢起红斑和水疱1个月就诊。既往有2型糖尿病病史10年,长期口服格列吡嗪控释片(南京易亨制药有限公司)10 mg,每日1次,阿卡波糖片(拜耳医药保健有限公司)100 mg,每日3次。因血糖控制不佳于2月前调整降血糖方案,加用苯甲酸阿格列汀片(武田药品工业株式会社大阪工厂,批号477753)25 mg,每日1次。随后患者血糖控制平稳,无明显不适。加用阿格列汀片20 d后,患者四肢皮肤出现散在红斑伴中度瘙痒,未予特殊处理,症状自行缓解。随后6 d患者四肢出现水疱、大疱,约绿豆至蚕豆大小,皮损逐渐增多、加重,瘙痒加剧,逐渐蔓延至全身(图1),遂来院就诊。患者否认有食物、药物过敏史,否认家族性自身免疫性疾病史。
作者 张羽 ZHANG Yu(Afiliated Hospital of Jianghan University,Hubei Wuhan 430015,China)
出处 《中国医院药学杂志》 CAS 北大核心 2022年第20期2201-2202,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献3

二级参考文献46

  • 1朱国兴,陆春,赖维,冯佩英,顾有守.大剂量静脉注射免疫球蛋白治疗25例重症皮肤病的临床分析[J].中华皮肤科杂志,2006,39(1):41-43. 被引量:21
  • 2王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:30
  • 3Ahrn B. Gut peptides and type 2 diabetes mellitus treatment [J]. Current diabetes reports, 2003, 3(5): 365-372.
  • 4Horie A, Tokuyama Y, Ishizuka T, et al. The Dipeptidyl Peptidase-4 Inhibitor Vildagliptin has the Capacity to Repair/3- Cell Dysfunction and Insulin Resistance[J]. Hormone and metabolic research : Hormon-und Stoffwechselforschung : Hormones et metabolisme, 2014, 46(11): 814-818.
  • 5Scheen AJ. A review of gliptins for 2014[J]. Expert opinion on pharmacotherapy, 2015, 16(1): 43-62.
  • 6Aschner P, Kipnes MS, Lunceford JK, et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes[J]. Diabetes care, 2006, 29(12): 2632-2637.
  • 7Seck T, Nauek M, Sheng D, et al. Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study [J]. International journal of clinical practice, 2010, 64 (5) : 562-576.
  • 8Harashima SI, Ogura M, Tanaka D, et al. Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combina- tion therapy on glycaemic control and insulin secretion capacity in type 2 diabetes[J]. International journal of clinical practice, 2012, 66(5): 465-476.
  • 9Yoon KH, Shockey GR, Teng R, et al. Effect of initial com- bination therapy with sitagliptin, a dipeptidyl peptidase-4 in- hibitor, and pioglitazone on glycemic control and measures of l-cell function in patients with type 2 diabetes[J]. Internation- al journal of clinical practice, 2011, 65(2) : 154-164.
  • 10Mathieu C, Shankar RR, Lorber D, et al. A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Admin- istration of Sitagliptin with Intensively Titrated Insulin Glargine[J]. Diabetes Therapy, 2015: 1-16.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部